[1] Lyon AR,Citro R,Schneider B,et al.Pathophysiology of takotsubo syndrome:JACC state-of-the-art review[J]. J Am Coll Cardiol,2021,77(7):902-921. [2] Ghadri JR,Wittstein IS,Prasad A,et al.International expert consensus document on takotsubo syndrome(part I):clinical characteristics,diagnostic criteria,and pathophysiology[J]. Eur Heart J,2018,39(22):2032-2046. [3] 邵望舒,姜雅秋,邵方举,等. 应激性心肌病研究进展[J]. 山东医药,2014,54(28):102-105. Shao WS,Jiang YQ,Shao FJ,et al.Research progress of stress cardiomyopathy[J]. Shandong Med J,2014,54(28):102-105. [4] 林燕,俞超,高春华,等. 1例肾移植术后患者合并应激性心肌病的急救与护理[J]. 中华护理杂志,2022,57(18):2252-2256. Lin Y,Yu C,Gao CH,et al.First aid and nursing care of a patient with induced stress cardiomyopathy after kidney transplantation[J]. Chin J Nurs,2022,57(18):2252-2256. [5] Templin C,Ghadri JR,Diekmann J,et al.Clinical features and outcomes of takotsubo(stress)cardiomyopathy[J]. N Engl J Med,2015,373(10):929-938. [6] de Chazal HM,Del Buono MG,Keyser-Marcus L,et al. Stress cardiomyopathy diagnosis and treatment:JACC state-of-the-art review[J]. J Am Coll Cardiol,2018,72(16):1955-1971. [7] Napp LG,Westenfeld R,Møller JE,et al.Impella mechanical circulatory support for takotsubo syndrome with shock:a retrospective multicenter analysis[J]. Cardiovasc Revasc Med,2022,40:113-119. [8] El-Battrawy I,Santoro F,Stiermaier T,et al.Prevalence,management,and outcome of adverse rhythm disorders in takotsubo syndrome:insights from the international multicenter GEIST registry[J]. Heart Fail Rev,2020,25(3):505-511. [9] 张欢,彭勇,廖雪莲. 重症患者应激性心肌病的常见病因及诊治原则[J]. 临床内科杂志,2022,39(2):80-83. Zhang H,Peng Y,Liao XL.Pathophysiology,diagnosis and management of stress cardiomyopathy in the critically ill[J]. J Clin Intern Med,2022,39(2):80-83. [10] Lee SJ,Sung TY.Emergence agitation:current knowledge and unresolved questions[J]. Korean J Anesthesiol,2020,73(6):471-485. [11] 冯昭妍,张松,俞卫锋. 成人全麻后苏醒期躁动的研究进展[J]. 临床麻醉学杂志,2021,37(7):769-772. Feng ZY,Zhang S,Yu WF.Advances in emergence agitation after general anesthesia in adults patients[J]. J Clin Anesthesiol,2021,37(7):769-772. [12] Biffi S,Di Bella S,Scaravilli V,et al.Infections during extracorporeal membrane oxygenation:epidemiology,risk factors,pathogenesis and prevention[J]. Int J Antimicrob Agents,2017,50(1):9-16. [13] Shah HN,Schwartz JL,Luna GY,et al.Bathing with 2% chlorhexidine gluconate:evidence and costs associated with central line-associated bloodstream infections[J]. Crit Care Nurs Q,2016,39(1):42-50. [14] Nguyen TP,Phan XT,Nguyen TH,et al.Major bleeding in adults undergoing peripheral extracorporeal membrane oxygenation(ECMO):prognosis and predictors[J]. Crit Care Res Pract,2022,2022:5348835. [15] Thomas J,Kostousov V,Teruya J.Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation[J]. Semin Thromb Hemost,2018,44(1):20-29. |